Goodrx is trading 7.1% up at $3.38 as investors position ahead of its Q2 2026 earnings report on August 05, 2026.
- The move comes during a strong risk-on session, with major U.S. indices rising approximately 2%.
- Market attention is focused on the stabilization of prescription transactions revenue and evolving competitive dynamics in the discount and telehealth sectors.